| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/11/2007 | US20070010861 Methods and devices for selective disruption of fatty tissue by controlled cooling |
| 01/11/2007 | US20070010658 Trimeric binding proteins for trimeric cytokines |
| 01/11/2007 | US20070010476 Therapy and diagnosis of conditions related to telomere length and/or telomerase activity |
| 01/11/2007 | US20070010448 Drug targets in Candida albicans |
| 01/11/2007 | US20070010442 Inhibitor of vascular endothelial cell growth factor |
| 01/11/2007 | US20070010418 For use in detergent, flour for producing a dough or a baked product |
| 01/11/2007 | US20070010018 Methods of screening for introduction of DNA into a target cell |
| 01/11/2007 | US20070010017 Lentiviral packaging constructs |
| 01/11/2007 | US20070010015 Complete empty viral particles of infectious bursal disease virus (ibdv), production method thereof and applications of same |
| 01/11/2007 | US20070010013 Oocytes derived from ovarian culture initially containing no oocytes |
| 01/11/2007 | US20070010012 Differentiation of primate pluripotent stem cells to cardiomyocyte-lineage cells |
| 01/11/2007 | US20070010011 Nutrient broth comprising fibroblast growth factor and cell-free matrix for use in propagation of primate embryonic stem cells |
| 01/11/2007 | US20070010010 Method for efficient transfer of human blastocyst-derived stem cell (hbs cells) from a feeder-supported to a feeder-free culture system |
| 01/11/2007 | US20070010009 Antibody Composition-Producing Cell |
| 01/11/2007 | US20070010008 Ex vivo expansion of primary animal cells |
| 01/11/2007 | US20070009991 Gene expression in transgenic avians |
| 01/11/2007 | US20070009989 Synthetic heparanase molecules and uses thereof |
| 01/11/2007 | US20070009985 Novel nitrile hydratase |
| 01/11/2007 | US20070009981 Nematode phosphoethanolamine N-methyltransferase-like sequences |
| 01/11/2007 | US20070009971 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 01/11/2007 | US20070009964 competing with natural OX40L for blocking OX40R-mediated cell signaling in the prophylaxis and/or treatment of diseases related to activated T cells |
| 01/11/2007 | US20070009957 Vectors used to create hybrid constant regions |
| 01/11/2007 | US20070009949 Paramyxovirus-derived RNP |
| 01/11/2007 | US20070009941 Complementary DNAs |
| 01/11/2007 | US20070009933 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 01/11/2007 | US20070009919 Detecting DNA damage by identifying the activation state of Ataxia Telangiectasia-Mutated kinase by determining the phosphorylation state of a specific serine residue; antibodies that recognize the phosphorylation state; drug screening for ATM kinase agonists |
| 01/11/2007 | US20070009882 In vitro platform for screening agents inducing islet cell neogenesis |
| 01/11/2007 | US20070009551 Aids ancestral viruses and vaccines |
| 01/11/2007 | US20070009550 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 01/11/2007 | US20070009546 Isolated nucleic acid; screening for antibacterial compounds |
| 01/11/2007 | US20070009538 Expression and export of angiogenesis inhibitors as immunofusins |
| 01/11/2007 | US20070009523 Polypeptide variants with altered effector function |
| 01/11/2007 | US20070009522 administering to an Rh-negative individual in need of an anti-Rh(D) monoclonal antibody, wherein monoclonal antibody exhibits a Fc gamma RTIII-type ADCC ( antibody-dependent cell-mediated cytotoxicity (ADCC) assays) level greater than 80% relative to a reference polyclonal anti-Rh(D) human antibody |
| 01/11/2007 | US20070009520 Osteoclastogenesis inhibitory factor-binding molecule (OBM) specific immunoglobulin for use inhibiting osteoclast inhibitory factor (OCIF) binding activity and treating bone disorders |
| 01/11/2007 | US20070009501 Squamous cell carcinoma antigens and use therefor |
| 01/11/2007 | US20070009499 Myoblast treatment of diseased or weakened organs |
| 01/11/2007 | US20070009498 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 01/11/2007 | US20070009497 Dendritic cell expanded T suppressor cells and methods of use thereof |
| 01/11/2007 | US20070009496 Method of growing myocardial cells |
| 01/11/2007 | US20070009494 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| 01/11/2007 | US20070009493 Chondrogenic compositions and methods of use |
| 01/11/2007 | US20070009492 Multipotent postnatal stem cells from human periodontal ligament and uses thereof |
| 01/11/2007 | US20070009491 For generation of neurons, oligodendrocytes and/or astrocytes; epidermal growth factors; culturing and allowing proliferation |
| 01/11/2007 | US20070009488 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules |
| 01/11/2007 | US20070009486 Adenoviral vectors having a protein IX deletion |
| 01/11/2007 | US20070009483 Compositions and methods for the therapeutic treatment of diabetes |
| 01/11/2007 | DE10350054B4 Rekombinantes Zellsystem zur Deorphansisierung von G Protein-gekoppelten Rezeptoren Recombinant cell system for Deorphansisierung of G protein-coupled receptors |
| 01/11/2007 | DE102005007311B4 Verfahren zur Erzeugung von Pflanzen mit verminderter Ruheperiode Process for the production of plants with reduced rest period |
| 01/11/2007 | CA2656548A1 Progenitor cells and uses thereof |
| 01/11/2007 | CA2655511A1 Methods of isolating cells and generating monoclonal antibodies |
| 01/11/2007 | CA2614066A1 Dehydrin genes and promoters from coffee |
| 01/11/2007 | CA2613940A1 Methods for tissue engineering |
| 01/11/2007 | CA2613867A1 Serum-free culture medium for the production of recombinant gonadotropins |
| 01/11/2007 | CA2613849A1 Use of human growth hormone in mouse carrying human hepatocytes |
| 01/11/2007 | CA2613640A1 Cell growth and cell transplant devices for gene therapy |
| 01/11/2007 | CA2612621A1 Heparin coating of biological tissue |
| 01/11/2007 | CA2612241A1 Human monoclonal antibodies to programmed death ligand 1 (pd-l1) |
| 01/11/2007 | CA2612239A1 Il-12/p40 binding proteins |
| 01/11/2007 | CA2611708A1 Serum-free stable transfection and production of recombinant human proteins in human cell lines |
| 01/10/2007 | EP1742059A1 Use of PTA peptides for stratification of individuals having cancer |
| 01/10/2007 | EP1741786A1 Method of separating precusror cells of liver cells, endothelial cells or hematopoietic cells from cell mass |
| 01/10/2007 | EP1741783A1 Human antiamyloid beta peptide antibody and antibody fragment thereof |
| 01/10/2007 | EP1741779A2 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine mediated toxicity |
| 01/10/2007 | EP1741776A1 Process for producing multipotential stem cell originating in testoid cell |
| 01/10/2007 | EP1741449A1 Preventive and/or remedy for cancer |
| 01/10/2007 | EP1740945A1 Non-invasive, in vitro functional tissue assay systems |
| 01/10/2007 | EP1740696A2 Isolation and culture of a high purity population of cone photoreceptor cells by tissue dissociation and pna-panning, and biological applications thereof |
| 01/10/2007 | EP1740695A1 Dual-transfected cells lines as in vitro screening tools for pharmaceutical compound profiling: a model for heptobiliary elimination |
| 01/10/2007 | EP1740615A2 Humanized anti-tgf-beta antibodies |
| 01/10/2007 | EP1740612A2 Pdx1 expressing endoderm |
| 01/10/2007 | EP1740220A2 Non-natural ribonuclease conjugates as cytotoxic agents |
| 01/10/2007 | EP1740219A2 Medical device with coating for capturing genetically-altered cells and methods of using same |
| 01/10/2007 | EP1740210A2 Irta-5 antibodies and their uses |
| 01/10/2007 | EP1740202A1 Use of luteinizing hormone (lh) and chorionic gonadotropin (hcg) for proliferation of neural stem cells and neurogenesis |
| 01/10/2007 | EP1513876B1 Human 5-ht7 receptor promoter sequence |
| 01/10/2007 | EP1451300A4 Methods and compositions for the use of stromal cells to support embryonic and adult stem cells |
| 01/10/2007 | EP1412509B1 Rna amplification system using plant components in animal cells |
| 01/10/2007 | EP1406680A4 Biofunctional fibers |
| 01/10/2007 | EP1339745B1 Immunotherapeutic methods and molecules |
| 01/10/2007 | EP1232180B1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 01/10/2007 | EP1228233B1 Methods and compositions comprising renilla gfp |
| 01/10/2007 | EP1078060B1 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 01/10/2007 | EP1035856B1 Isolated dna encoding human h3 histamine receptor |
| 01/10/2007 | EP1017723B1 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
| 01/10/2007 | EP1015613B1 Control pod dehiscence or shatter |
| 01/10/2007 | EP0949331B1 Established microglia |
| 01/10/2007 | EP0934423B1 Aav-dna helper virus sequences |
| 01/10/2007 | EP0918796B1 Monoclonal antibody which agglutinates e. coli having the cs4-cfa/i family protein |
| 01/10/2007 | EP0812357B1 A method for making heteromultimeric polypeptides |
| 01/10/2007 | CN1894408A Metabolic protein for weed-control agent, its gene, and its use |
| 01/10/2007 | CN1894406A Antibody composition-producing cell |
| 01/10/2007 | CN1894404A Promoter in the presence of organic acid and utilization thereof |
| 01/10/2007 | CN1894402A FLP-mediated recombination |
| 01/10/2007 | CN1894401A Derivation of terminally differentiated dopaminergic neurons from human embryonic stem cells |
| 01/10/2007 | CN1894400A Serum-free VERO cell banking process |
| 01/10/2007 | CN1894396A Drug testing system with bio-artificial liver |
| 01/10/2007 | CN1894275A Human EPO mimetic hinge core mimetibodies, compositions, methods and uses |
| 01/10/2007 | CN1893971A A method for increasing CD8<+> cytotoxic T cell reponses and for treating multiple sclerosis |
| 01/10/2007 | CN1893968A Regulation of sperm function |
| 01/10/2007 | CN1891826A Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |